Overview

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

Status:
Completed
Trial end date:
2014-11-29
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to study the safety and tolerability of a HIV drug and to evaluate a decrease of HIV-1 virus level in blood after treatments in HIV-1 infected patients
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb
ViiV Healthcare
Collaborator:
GlaxoSmithKline
Treatments:
Atazanavir Sulfate
BMS-955176
Emtricitabine
Ritonavir
Tenofovir